Results Per Page:

Now showing items 1-6 of 2

acute lymphoblastic leukemia (2)
targeted therapies (2)
BH3 mimetic resistance (1)
Mcl-1 (1)
mTOR inhibition (1)
synergistic apoptosis (1)